Skip to main content
Figure 2 | Molecular Neurodegeneration

Figure 2

From: T cell mediated cerebral hemorrhages and microhemorrhages during passive Aβ immunization in APPPS1 transgenic mice

Figure 2

Schematic illustration of the experimental in vivo approach and the incidence of bleedings in APPPS1 transgenic mice. (A) We immunized T-GFP mice with Aβ42 and adoptively transferred these isolated T cells via the tail vein into transgenic or control mice. After a recovery period of one week, a cranial window surgery with dura removal and antibody application of either antibody 10D5 against Aβ or control antibody 16D5 against human tau was performed. Brains were analyzed postmortem 3 to 4 days after passive immunization. (B) In contrast to wildtype mice passively immunized (left image) or APPPS1 transgenic mice immunized with a control antibody against human tau (right image) transgenic mice immunized with anti Aβ antibody developed acute hematomas on both hemispheres as indicated by black arrows (image in the middle).

Back to article page